Rohto Pharmaceutical Co.,Ltd. (TYO: 4527)
Japan
· Delayed Price · Currency is JPY
3,571.00
-16.00 (-0.45%)
Oct 10, 2024, 10:04 AM JST
Rohto Pharmaceutical Co.,Ltd. Revenue
Rohto Pharmaceutical Co.,Ltd. had revenue of 68.36B JPY in the quarter ending June 30, 2024, with 11.75% growth. This brings the company's revenue in the last twelve months to 278.03B, up 12.30% year-over-year. In the fiscal year ending March 31, 2024, Rohto Pharmaceutical Co.,Ltd. had annual revenue of 270.84B with 13.48% growth.
Revenue (ttm)
278.03B
Revenue Growth
+12.30%
P/S Ratio
2.92
Revenue / Employee
38.30M
Employees
7,259
Market Cap
813.09B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 270.84B | 32.18B | 13.48% |
Mar 31, 2023 | 238.66B | 39.02B | 19.54% |
Mar 31, 2022 | 199.65B | 18.36B | 10.13% |
Mar 31, 2021 | 181.29B | -7.04B | -3.74% |
Mar 31, 2020 | 188.33B | 4.75B | 2.58% |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition